Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-047821

President and CEO sold 4,807 shares at $12.09 ($58,117)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Touchon Pascal President and CEO 2020-08-18 Sale −4,807 $12.09 $58,117 260,037 D: show line 1 in the form
Open-market sales · 4,807 sh · avg $12.09 · $58,117
Loading xslF345X03/doc4.xml…